Wednesday, May 25, 2022, 1:00 pm to 3:00 pm (registration required)
In December 2021, the National Human Genome Research Institute (NHGRI) hosted a historic symposium that addressed the history of eugenics and scientific racism and their complex legacies in the modern health sciences. The symposium illustrated the urgent need for more public discussion on the connection between existing and emerging genetic and genomic screening technologies and the legacies of eugenics.
Eugenics and scientific racism are immoral and pseudoscientific ideologies and practices that have historically been used to marginalize and dehumanize both individuals and groups. Those practices continue to harm people in the U.S. and worldwide, despite having been rejected by NIH, NHGRI and the scientific community.
Join us on Wednesday, May 25, as scholars and scientists answer audience questions and address the complexities surrounding historical and present-day eugenics and scientific racism in the context of existing and developing genetic and genomic screening technologies.
This will include characterizing the historical connections between the eugenics movement and genetic counseling, as well as charting the development of contemporary genetic counseling, reproductive choice and clinically informed decision-making.
Click here to register for this virtual event, which will take place on Zoom.
Wednesday, May 25, 2022, 1:00 pm to Thursday, May 26, 2022, 5:00 pm (registration required)
Cancer health disparities affect millions of people across the United States. They remain stubbornly entrenched in the US health care system and disproportionally affect the underserved and underrepresented populations. Disparities in cancer burden are evident by geography, race/ethnicity, genetic ancestry, immigrant status, culture, gender, sexual orientation (LGBTQ+), and socioeconomic class. The elimination of cancer health disparities is a National Cancer Institute (NCI) research priority with the aim to achieve health equity and to reduce the overall burden of cancer in the United States. NCI seeks to expand cancer health disparity research within the extramural and intramural research programs.
As part of intramural research, the NCI Division of Cancer Epidemiology & Genetics (DCEG) and the NCI Center for Cancer Research (CCR) are recognizing the significance of this task and teamed up for this workshop to showcase successful health disparity research and have a discussion of barriers. This virtual workshop seeks to communicate the expectations of health disparity research, resources to investigate cancer health disparities, opportunities for collaborations, and future directions.
Wednesday, June 1, 2022, 11:00 am to Thursday, June 2, 2022, 5:15 pm (registration required)
On June 1st and 2nd, the NIH Pain Consortium will convene the 17th Annual NIH Pain Consortium Symposium on Advances in Pain Research via a virtual platform. The symposium, titled “Pain Management Through the Lens of Whole Person Health,” will address the application of a “whole person” lens to pain conditions along the spectrum of translational science, from the biological basis to multicomponent interventions and treatment that will ultimately improve patient outcomes and pain management. Topics will include the consideration of pain conditions and models through the lens of whole person health, integrating data science and multi-modal approaches into analyses and treatments, and methods for engaging patients and other stakeholders in the whole person approach to pain management.
Click here to register for this virtual event.
Thursday, June 2, 2022, 9:00 am to Friday, June 3, 2022, 5:00 pm (register by May 30)
Cystic fibrosis (CF) is a rare inherited disease caused by mutations in a gene called the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Mutations in CFTR cause significant morbidity and mortality for patients with CF, primarily affecting the lungs and digestive systems. With no cure for CF, advances in treatment using highly effective modulator therapies (HEMT) are helping patients live longer lives with improvements in clinical outcomes.
On Thursday, June 2, and Friday, June 3, 2022, the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), in planning collaboration with the Cystic Fibrosis Foundation, will host a virtual workshop with the objective to bring together experts in Cystic Fibrosis (CF) clinical-translational research to address critical questions and inform the field of the future research needs in the era of highly effective modulator therapies (HEMT) for the treatment of CF. The workshop will highlight challenges and opportunities for research in the context of rapidly shifting treatment options. The workshop is free, open to the public, and will be recorded.
Register by May 30 to participate.
Friday, June 3, 2022, 1:00 pm to 4:30 pm (registration required)
The 15th annual NIH Matilda White Riley Behavioral and Social Sciences Honors will feature a keynote address from the 2022 Distinguished Lecturer, Dr. David R. Williams, titled "The Virus of Racism: Understanding its Threats, Mobilizing Defenses." The virtual event will also highlight innovative research from five Early-Stage Investigator (ESI) Honorees, who were selected out of more than 250 submissions to our ESI paper competition, to present their recent behavioral and social sciences research findings.
In the keynote presentation, Dr. David Williams will provide an overview of how socioeconomic, racial, and ethnic status affect health. He will describe the added burden of race by outlining the multiple ways by which racism in the larger society adversely affects physical and mental health of racially and ethnically disadvantaged populations. He will also highlight evidence regarding promising interventions, at the individual and community level, that can enhance health and reduce racial and ethnic inequities in health. Dr. Williams is an elected member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the National Academy of Sciences. He has been ranked as the Most Cited Black Scholar in the Social Sciences and as one of the World’s Most Influential Scientific Minds.
Click here to register for the event. The event will be webcast live and is open to the public.
Thursday, June 16, 2022, 11:00 am to Friday, June 17, 2022, 5:30 pm (registration required)
This virtual workshop, organized by the National Heart, Lung, and Blood Institute (NHLBI), will bring together basic and clinical scientists to review the state of the science and identify key knowledge gaps and research opportunities to further our understanding of sex/gender differences in COVID-19 outcomes that are relevant to heart, lung, blood, and sleep (HLBS) disorders. A better understanding of the factors that might contribute to sex/gender-specific health outcomes will improve our ability to develop sex/gender-specific prevention, intervention, and implementation strategies for COVID-19-related HLBS disorders. Ultimately, this enhanced understanding will enable novel approaches to facilitate translation of basic biological discoveries into safe and effective clinical applications.